| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.27 |
6e-08 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.23 |
3e-06 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.22 |
3e-06 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-05 |